Advancing Business, Technology and Innovation for Vaccines in South East Asia
South East Asia vaccine market is rapidly emerging as a significant player within the global vaccine industry, driven by increased investments, technological advancements, and governmental support. Countries such as Thailand, Indonesia, Malaysia, the Philippines, and Vietnam are leading the charge, offering unique advantages for major pharmaceutical and biopharmaceutical companies, including robust research capabilities and favorable regulatory environments. As the industry continues to expand, the region is poised to deliver even more exciting developments in vaccines.
Collaboration among South East Asian nations and international partners, coupled with efficient pandemic response measures and streamlined regulatory processes, further solidifies the region's position in vaccine development and distribution. The COVID-19 pandemic has particularly emphasized the market potential of South East Asia, showcasing its crucial role in addressing global health crises.
Vaccine World South East Asia 2024 stands as a premier destination for all things vaccine-related in the South East Asia region. It provides a vital platform for industry stakeholders to convene and explore the latest advancements in vaccine research and development within the region. Experts from Thailand, Malaysia, Indonesia, Vietnam, and beyond gather to discuss innovative manufacturing processes and cutting-edge technologies shaping the future of vaccines in South East Asia. With a focus on collaboration, knowledge exchange, and showcasing groundbreaking case studies, the conference are driven by a common goal: transforming innovative concepts into actionable solutions, accelerate research initiatives, bolster manufacturing capabilities, and integrate novel technologies to revolutionize vaccine development in the region.
.
.
.
.
.
.
“Very informative and good opportunity for networking.”
“Enriching perspectives about vaccines development shared between academia and industry.”
“Great lineup of leaders. Their sometimes contradictory positions provided extra value as seeing probing arguments on both sides of a topic.”
“IMAPAC does a great job of bringing a lot of regional players to one event and we’ve benefitted from speaking to a lot of decision-makers from Vaccine manufacturers around Asia, particularly India, Korea, Singapore and some from Australia as well.”
“There have been great speakers, and in particular, great audience participation, which is a key aspect to a successful meeting, and at the tea breaks and lunch there have been fabulous opportunities for networking. This conference is important because it really brings together the regional players in the vaccine space, so you get to meet different people from organisations within SEA particularly and get their insights into what’s happening in Vaccines. If you go to a US meeting you won’t get that perspective. So that’s why I come to meetings like this one to find out what’s happening in this part of the world.”
The conference was a rewarding experience, with insightful presentations. The intimate setting fostered personal interactions and meaningful discussions, enhancing the overall learning experience.
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2023 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
